Skip to main content
TipRanks
Go Ultimate75% OFF

Mostafa Kamal Insider Profile

4 Followers

Mostafa Kamal, former CEO, Magellan Rx Management at Magellan Health, holds 0.00 shares in Magellan Health (Ticker: MGLN).

Mostafa Kamal's Trading History

MGLN
Magellan Health
Jan 04, 2022―Uninformative Sell―$0.00
MGLN
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 04, 2022Uninformative Sell$0.005,994$0.00―
Nov 17, 2020Uninformative Buy$1.42M20,885$67.79―
Nov 17, 2020Uninformative Sell$1.77M20,885$84.82―
Nov 12, 2020Uninformative Buy$399.42K6,000$66.57―
Nov 12, 2020Uninformative Sell$489.42K6,000$81.57―

You May Also Like

Mostafa Kamal insider profile FAQ

What is the percentage of profitable transactions made by Mostafa Kamal?
The percentage of profitable transactions made by Mostafa Kamal is 0%.
What is the average return per transaction made by Mostafa Kamal?
The average return per transaction made by Mostafa Kamal is -20.10%.
What stocks does Mostafa Kamal hold?
Mostafa Kamal holds: MGLN stocks.
What was Mostafa Kamal's most profitable transaction?
Mostafa Kamal’s most profitable transaction was an Informative Buy of MGLN stock on September 8, 2017. The return on the trade was -6.80%.
What is Mostafa Kamal's role in Magellan Health?
Mostafa Kamal's role in Magellan Health is CEO, Magellan Rx Management.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.